Literature DB >> 18440729

Effect of 11C-methionine-positron emission tomography on gross tumor volume delineation in stereotactic radiotherapy of skull base meningiomas.

Sabrina T Astner1, Mihaela Dobrei-Ciuchendea, Markus Essler, Ralf A Bundschuh, Heitetsu Sai, Markus Schwaiger, Michael Molls, Wolfgang A Weber, Anca-Ligia Grosu.   

Abstract

PURPOSE: To evaluate the effect of trimodal image fusion using computed tomography (CT), magnetic resonance imaging (MRI) and (11)C-methionine positron emission tomography (MET-PET) for gross tumor volume delineation in fractionated stereotactic radiotherapy of skull base meningiomas. PATIENTS AND METHODS: In 32 patients with skull base meningiomas, the gross tumor volume (GTV) was outlined on CT scans fused to contrast-enhanced MRI (GTV-MRI/CT). A second GTV, encompassing the MET-PET positive region only (GTV-PET), was generated. The additional information obtained by MET-PET concerning the GTV delineation was evaluated using the PET/CT/MRI co-registered images. The sizes of the overlapping regions of GTV-MRI/CT and GTV-PET were calculated and the amounts of additional volumes added by the complementing modality determined.
RESULTS: The addition of MET-PET was beneficial for GTV delineation in all but 3 patients. MET-PET detected small tumor portions with a mean volume of 1.6 +/- 1.7 cm(3) that were not identified by CT or MRI. The mean percentage of enlargement of the GTV using MET-PET as an additional imaging method was 9.4% +/- 10.7%.
CONCLUSIONS: Our data have demonstrated that integration of MET-PET in radiotherapy planning of skull base meningiomas can influence the GTV, possibly resulting in an increase, as well as in a decrease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18440729     DOI: 10.1016/j.ijrobp.2008.02.058

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  [Technical and methodical developments of radiation oncology from a physician's point of view].

Authors:  N Willich
Journal:  Strahlenther Onkol       Date:  2012-11       Impact factor: 3.621

2.  Respiratory gated [18F]FDG PET/CT for target volume delineation in stereotactic radiation treatment of liver metastases.

Authors:  R A Bundschuh; N Andratschke; J Dinges; M N Duma; S T Astner; M Brügel; S I Ziegler; M Molls; M Schwaiger; M Essler
Journal:  Strahlenther Onkol       Date:  2012-03-24       Impact factor: 3.621

Review 3.  Diagnostic challenges in meningioma.

Authors:  Martha Nowosielski; Norbert Galldiks; Sarah Iglseder; Philipp Kickingereder; Andreas von Deimling; Martin Bendszus; Wolfgang Wick; Felix Sahm
Journal:  Neuro Oncol       Date:  2017-11-29       Impact factor: 12.300

Review 4.  The use of FDG-PET to target tumors by radiotherapy.

Authors:  Guido Lammering; Dirk De Ruysscher; Angela van Baardwijk; Brigitta G Baumert; Jacques Borger; Ludy Lutgens; Piet van den Ende; Michel Ollers; Philippe Lambin
Journal:  Strahlenther Onkol       Date:  2010-08-30       Impact factor: 3.621

5.  Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.

Authors:  Hideyuki Arita; Manabu Kinoshita; Yoshiko Okita; Ryuichi Hirayama; Tadashi Watabe; Kayako Ishohashi; Noriyuki Kijima; Naoki Kagawa; Yasunori Fujimoto; Haruhiko Kishima; Eku Shimosegawa; Jun Hatazawa; Naoya Hashimoto; Toshiki Yoshimine
Journal:  J Neurooncol       Date:  2011-11-17       Impact factor: 4.130

6.  Tumour volume delineation in prostate cancer assessed by [11C]choline PET/CT: validation with surgical specimens.

Authors:  Ralph A Bundschuh; Christina M Wendl; Gregor Weirich; Mathias Eiber; Michael Souvatzoglou; Uwe Treiber; Hubert Kübler; Tobias Maurer; Jürgen E Gschwend; Hans Geinitz; Anca L Grosu; Sibylle I Ziegler; Bernd Joachim Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-07       Impact factor: 9.236

7.  5-Aminolevulinic Acid and (18)F-FET-PET as Metabolic Imaging Tools for Surgery of a Recurrent Skull Base Meningioma.

Authors:  Jan Frederick Cornelius; Philipp Jörg Slotty; Gabriele Stoffels; Norbert Galldiks; Karl Josef Langen; Hans Jakob Steiger
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-01

8.  Potential impact of (68)Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas.

Authors:  Fonyuy Nyuyki; Michail Plotkin; Reinhold Graf; Roger Michel; Ingo Steffen; Timm Denecke; Lilli Geworski; Daniel Fahdt; Winfried Brenner; Reinhard Wurm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-18       Impact factor: 9.236

9.  In vivo metabolism of tryptophan in meningiomas is mediated by indoleamine 2,3-dioxygenase 1.

Authors:  Ian M Zitron; David O Kamson; Sam Kiousis; Csaba Juhász; Sandeep Mittal
Journal:  Cancer Biol Ther       Date:  2013-01-28       Impact factor: 4.742

10.  [68Ga]-DOTATOC-PET/CT for meningioma IMRT treatment planning.

Authors:  Barbara Gehler; Frank Paulsen; Mehmet O Oksüz; Till-Karsten Hauser; Susanne M Eschmann; Roland Bares; Christina Pfannenberg; Michael Bamberg; Peter Bartenstein; Claus Belka; Ute Ganswindt
Journal:  Radiat Oncol       Date:  2009-11-18       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.